Loading clinical trials...

COVID-19 Seroprevalence in Pregnant Women and Blood Donors | Clinical Trials | Clareo Health

COMPLETED

COVID-19 Seroprevalence in Pregnant Women and Blood Donors

SARS-CoV-2 sERoprévalences Dans la Population Des Femmes Enceintes et Donneurs de Sang

NCT04893057•Centre Hospitalier Universitaire de Besancon

Summary

The study aims to measure the SARS-CoV-2 seroprevalence (ie. the proportion of people with antibodies against the virus) in pregnant women and blood donors in an administrative area of France, and to determine whether these measures are representative of the general population.

Eligibility

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Pregnant women
•* Adult female
•* Admitted to hospital for live birth
•* Informed consent
•* Affiliated to the French social security health insurance scheme
•Blood donors
•* Adult male or female
•* Qualified for whole blood donation (up to 70 years old in France)
•* Informed consent
•* Affiliated to the French social security health insurance scheme

Exclusion Criteria

•Legal incapacity or limited legal capacity
•Subject without health insurance coverage
•Exclusion period of another study or exclusion period of the French national healthy volunteer registry

Locations (1)

CHU de besançon

Besançon, France

Key Dates

Start Date

September 15, 2022

Primary Completion Date

January 4, 2023

Completion Date

January 4, 2023

Last Updated

October 4, 2024

Enrollment

797

ACTUAL participants

Conditions

COVID-19 Respiratory Infection

Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure

NCT05562505

Mechanical Ventilation ComplicationHypoxemia+4 more

View study

ACTIVE_NOT_RECRUITING

Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2

NCT05040659

AnosmiaAsymptomatic COVID-19+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 4, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

COVID-19 Seroprevalence in Pregnant Women and Blood Donors

Inclusion Criteria

Exclusion Criteria

Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure

Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2

Exercise and COVID-19 Viral T-cell Immunity

Lung Structure-Function In SurVivors of Mild and SEvere COVID-19 Infection: 129Xe MRI

Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit

Cromolyn Sodium for Treatment of COVID-19 Pneumonia